Home | Division of Cancer Prevention

Making cancer prevention possible

Cancer Prevention word cloud with the science's keywords.

Advancing Cancer Prevention: A Conversation with NCI’s Dr. Philip Castle

Philip Castle, Ph.D., M.P.H., joined NCI in July 2020 as director of the Division of Cancer Prevention (DCP). Dr. Castle previously worked at NCI in the Division of Cancer Epidemiology and Genetics (2002–2010), where he led numerous research projects, including studies of HPV and its connection to cervical and anal cancers. To mark his first year as DCP director, Dr. Castle discusses DCP’s priority areas and his vision for making more rapid progress in cancer prevention.

An image of a person getting vaccinated.

Vaccine to Prevent Hereditary Cancers Nears Human Trials

One of the first-ever vaccines for the prevention of colorectal and other cancers in patients at high genetic risk for these malignancies is expected to start its early phase safety and immunogenicity trial in the first quarter of 2022, according to investigators.

MISSION STATEMENT

The Division of Cancer Prevention furthers the mission of the National Cancer Institute by leading, supporting, and promoting rigorous, innovative research and training to prevent cancer and its consequences to improve the health of all people.

Commemoration of the 50th Anniversary of the National Cancer Act - Champions and Changemakers

Portrait of Sir Richard Peto (left) and Sir Richard Doll (right)

Sir Richard Peto, F.R.S. & Sir Richard Doll, M.D.
Avoidable Causes of Cancer

The collaborative genius of Oxford University’s Sir Richard Doll, M.D., and Sir Richard Peto, F.R.S., produced a blueprint for avoidable causes of cancer more than 4 decades ago that largely hold true, even today.

Mary-Claire King, Ph.D.
Discovering the Hereditary Breast Cancer Gene

Long before scientists completed mapping the human genome in 2003, geneticist Mary-Claire King discovered BRCA1, the first gene for a hereditary form of breast cancer.

Anna Suk-Fong Lok, M.D.
Viral Hepatitis and Early Detection of Liver Cancer

Anna Suk-Fong Lok, M.D., has devoted her career to studying the human toll of viral hepatitis, specifically Hepatitis B virus (HBV) and Hepatitis C virus (HCV) infections. Viral hepatitis and accompanying liver disease are among the major factors contributing to liver cancer, a disease...

Jimmie C. Holland, M.D.
Founder of Psycho-Oncology

Over a 40-year career, Jimmie C. Holland, M.D., focused on how patients feel about their treatment and how people responded emotionally and psychologically to life-threatening illnesses. She called this focus “psychological care of the medically ill,” and encouraged oncologists who were...

Latest News

Read All News

Meetings and Events

Review our past Meetings and Events

Translational Advances in Cancer Prevention Agent Development Virtual Workshop on Immunomodulatory Agents

Date(s):

Monday, September 13, 2021 - 10:00am - 5:00pm EDT
Tuesday, September 14, 2021 - 9:50am - 4:00pm EDT

Location: Virtual

Advancing Cancer Prevention: A Conversation with NCI’s Dr. Philip Castle

Vaccine to Prevent Hereditary Cancers Nears Human Trials

MISSION STATEMENT

Commemoration of the 50th Anniversary of the National Cancer Act - Champions and Changemakers

Latest News

Nutrition Frontiers - Spring 2021

The Search for Early Detection of Pancreatic Cancer Accelerates with Biomarkers

DCP/PREVENT-funded Project Presentations at AACR Virtual Annual Meeting I, April 9-15 2021

Pancreatic Cysts Are Monitored in New Trial Aimed at Reducing Cancer Risk Through Targeted Screening

Meetings and Events

Translational Advances in Cancer Prevention Agent Development Virtual Workshop on Immunomodulatory Agents

Twitter Feeds

@NCIprevention

@NCISymptomMgmt

@NCICastle

Policies

NCI's PDQ® Evidence-based Summaries

General Information

Search form

Advancing Cancer Prevention: A Conversation with NCI’s Dr. Philip Castle

Vaccine to Prevent Hereditary Cancers Nears Human Trials

MISSION STATEMENT

Commemoration of the 50th Anniversary of the National Cancer Act - Champions and Changemakers

Latest News

Nutrition Frontiers - Spring 2021

The Search for Early Detection of Pancreatic Cancer Accelerates with Biomarkers

DCP/PREVENT-funded Project Presentations at AACR Virtual Annual Meeting I, April 9-15 2021

Pancreatic Cysts Are Monitored in New Trial Aimed at Reducing Cancer Risk Through Targeted Screening

Meetings and Events

Translational Advances in Cancer Prevention Agent Development Virtual Workshop on Immunomodulatory Agents

Twitter Feeds

@NCIprevention

@NCISymptomMgmt

@NCICastle

Follow us at: